Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of subcutaneous dexmedetomidine in healthy volunteers
2015-004698-34Phase 4Completed
- Sponsor
- University of Turku
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in sedation, sponsored by University of Turku. Primary endpoint: Absolute bioavailability of subcutaneous dexmedetomidine. Started Jan 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on 2015-004698-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004698-34.